ASCP's Tim Webster to retire
Dapagliflozin Improves Health Outcomes for Adolescents With Type 1 Diabetes
The drug could also reduce chronic kidney disease when combined with insulin therapy.
The Potential Impact Pharmaceutical Tariffs May Have on Pharmacies
Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.
Gut Microbiome Composition Could Be Linked With Risk of Cognitive Impairment
In the study, the composition of the gut microbiome could also be affected by food insecurity, a known social determinant of health.
Scripted for Her: Addressing Preconception Health Through MTM
In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.
Importance of Skin-Gut Axis Communication in Homeostasis
The review explored the “emerging” term gut-skin axis and aimed to decipher the bidirectional signaling of the skin and gastrointestinal tract during homeostatic and disease states.
Mark Cuban Cost Plus Drugs, 9amHealth Collaborate to Make Obesity Medications Affordable
The program will include branded obesity glucagon-like peptide-1 medications, which will have a transparent monthly cost.
